Induction of cell surface human leukocyte antigen-G expression in pandemic H1N1 2009 and seasonal H1N1 influenza virus-infected patients.

[1]  N. Rouas-Freiss,et al.  Immunosuppressive HLA-G molecule is upregulated in alveolar epithelial cells after influenza A virus infection. , 2009, Human immunology.

[2]  J. Peiris,et al.  A novel H1N1 virus causes the first pandemic of the 21st century , 2009, European journal of immunology.

[3]  Shiyong Chen,et al.  Induction of both membrane-bound and soluble HLA-G expression in active human cytomegalovirus infection. , 2009, The Journal of infectious diseases.

[4]  Hideo Goto,et al.  In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses , 2009, Nature.

[5]  M. Mizuguchi,et al.  ORIGINAL ARTICLE: H3N2 Influenza A Virus Replicates in Immortalized Human First Trimester Trophoblast Cell Lines and Induces Their Rapid Apoptosis , 2009, American journal of reproductive immunology.

[6]  Marion Koopmans,et al.  Pathogenesis and Transmission of Swine-Origin 2009 A(H1N1) Influenza Virus in Ferrets , 2009, Science.

[7]  P. Shao,et al.  Novel swine-origin influenza virus A (H1N1): the first pandemic of the 21st century. , 2009, Journal of the Formosan Medical Association = Taiwan yi zhi.

[8]  M. Bouvier,et al.  MHC class I antigen presentation: learning from viral evasion strategies , 2009, Nature Reviews Immunology.

[9]  Rahul Raman,et al.  Transmission and Pathogenesis of Swine-Origin 2009 A(H1N1) Influenza Viruses in Ferrets and Mice , 2009, Science.

[10]  David Burgner,et al.  HLA and Infectious Diseases , 2009, Clinical Microbiology Reviews.

[11]  E. Carosella,et al.  HLA-G-dependent suppressor cells: Diverse by nature, function, and significance. , 2008, Human immunology.

[12]  Philippe Moreau,et al.  HLA-G: from biology to clinical benefits. , 2008, Trends in immunology.

[13]  F. Gros,et al.  Soluble HLA‐G molecules impair natural killer/dendritic cell crosstalk via inhibition of dendritic cells , 2008, European journal of immunology.

[14]  S. Ferrone,et al.  Soluble HLA-G: Are they clinically relevant? , 2007, Seminars in cancer biology.

[15]  M. Zhu,et al.  HLA-G expression in human ovarian carcinoma counteracts NK cell function. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  H. Wiendl,et al.  HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation. , 2007, Blood.

[17]  R. Apps,et al.  A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1 , 2007, European journal of immunology.

[18]  N. Rouas-Freiss,et al.  Modulation of HLA-G and HLA-E expression in human neuronal cells after rabies virus or herpes virus simplex type 1 infections. , 2007, Human immunology.

[19]  J. McCluskey,et al.  Structural studies on HLA-G: implications for ligand and receptor binding. , 2007, Human immunology.

[20]  E. Carosella,et al.  Functions of HLA-G in the immune system. , 2007, Tissue antigens.

[21]  Huimin Xu,et al.  Modulation of HLA expression in human cytomegalovirus immune evasion. , 2007, Cellular & molecular immunology.

[22]  F. Gros,et al.  Elevated levels of soluble non‐classical major histocompatibility class I molecule human leucocyte antigen (HLA)‐G in the blood of HIV‐infected patients with or without visceral leishmaniasis , 2006, Clinical and experimental immunology.

[23]  E. Carosella,et al.  Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. , 2006, Blood.

[24]  Judith E. Cartwright,et al.  Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. , 2006, Blood.

[25]  N. Rouas-Freiss,et al.  Modulation of HLA-G Expression in Human Neural Cells after Neurotropic Viral Infections , 2005, Journal of Virology.

[26]  M. Weller,et al.  Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. , 2005, Brain : a journal of neurology.

[27]  Wei Zhang,et al.  Tolerization of dendritic cells by HLA‐G , 2005, European journal of immunology.

[28]  H. Grosse-wilde,et al.  Detection of HLA-G5 secreting cells. , 2003, Human immunology.

[29]  S. Ferrone,et al.  Soluble HLA‐A,‐B,‐C and ‐G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation , 2003, European journal of immunology.

[30]  J. Dausset,et al.  Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule , 2002, AIDS.

[31]  J. Dausset,et al.  Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: A CD4+ T cell regulatory mechanism , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Dausset,et al.  HLA-G2, -G3, and -G4 Isoforms Expressed as Nonmature Cell Surface Glycoproteins Inhibit NK and Antigen-Specific CTL Cytolysis1 , 2001, The Journal of Immunology.

[33]  J. Dausset,et al.  Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. , 2000, Human immunology.

[34]  P. André,et al.  Modulation of HLA-G Antigens Expression by Human Cytomegalovirus: Specific Induction in Activated Macrophages Harboring Human Cytomegalovirus Infection1 , 2000, The Journal of Immunology.

[35]  J. Dausset,et al.  HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. , 1999, International immunology.

[36]  J. Dausset,et al.  The immunotolerance role of HLA-G. , 1999, Seminars in cancer biology.

[37]  P. Keskinen,et al.  Regulation of HLA class I and II expression by interferons and influenza A virus in human peripheral blood mononuclear cells , 1997, Immunology.

[38]  Neeloo Singh,et al.  Infectious diseases and immunity: special reference to major histocompatibility complex. , 1997, Emerging infectious diseases.